Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-1,4-glycosidic bonds are the primary chemical linkages that connect glucose monomers in dietary starches, including amylose and amylopectin [PubChem]. These bonds serve as a critical energy reservoir in plants and are a major source of dietary calories for humans [NIH]. During digestion, these linkages are hydrolyzed by enzymes such as salivary and pancreatic alpha-amylase and intestinal alpha-glucosidases to release glucose for absorption into the bloodstream [StatPearls]. The rate of this hydrolysis is a key factor in postprandial glycemic control, making the process a significant focus in the management of metabolic diseases like Type 2 diabetes [PubMed]. While the bonds themselves are substrates rather than therapeutic protein targets, they are the functional site of action for drugs like acarbose and miglitol, which inhibit the enzymes responsible for their cleavage [Mayo Clinic]. By slowing the breakdown of these bonds, these medications reduce the magnitude of blood glucose spikes after meals [Journal of Diabetes Investigation]. However, the inhibition of starch digestion can lead to the fermentation of undigested carbohydrates in the colon, resulting in side effects such as flatulence and osmotic diarrhea [NCBI].
Competitive inhibition of alpha-amylase and alpha-glucosidase enzymes to prevent the hydrolysis of alpha-1,4-glycosidic bonds.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-1,4-glycosidic bond.